Web Analytics

3 Latest Announced Rounds

  • $80,000,000
    Series C

    2 Investors

    Biotechnology Research
    Jan 10th, 2025
  • $2,200,000
    Pre-Seed

    2 Investors

    Technology, Information and Internet
    Jan 10th, 2025
  • $20,000,000
    Series A

    1 Investors

    Financial Services
    Jan 10th, 2025
$1,369.67M Raised in 48 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ataraxis AI

start up
United States - New York, NY
  • 01/11/2024
  • Seed
  • $4,000,000

Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data.

Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.


Related People

Jan Witowski MD PhDFounder

Jan Witowski MD PhD United States - New York, New York

CEO and co-founder of Ataraxis AI. Physician-scientist. Previously postdoc at NYU Langone Health, Harvard Medical School & Mass General. 10 years of experience in medical image processing, with focus on artificial intelligence, cancer imaging, and developing clinical diagnostic tools.



Submit A Correction
Submit A Correction

Submit The Correction On the Page